Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5080181
Max Phase: Preclinical
Molecular Formula: C46H76N12O9
Molecular Weight: 941.19
Molecule Type: Unknown
Associated Items:
ID: ALA5080181
Max Phase: Preclinical
Molecular Formula: C46H76N12O9
Molecular Weight: 941.19
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
Standard InChI: InChI=1S/C46H76N12O9/c1-27(2)24-34(40(61)52-29(5)38(59)54-33(45(66)67)17-11-21-51-46(49)50)55-41(62)36-18-13-23-58(36)44(65)35(25-28(3)4)56-42(63)37-19-12-22-57(37)43(64)32(16-9-10-20-47)53-39(60)31(48)26-30-14-7-6-8-15-30/h6-8,14-15,27-29,31-37H,9-13,16-26,47-48H2,1-5H3,(H,52,61)(H,53,60)(H,54,59)(H,55,62)(H,56,63)(H,66,67)(H4,49,50,51)/t29-,31+,32+,33+,34+,35+,36+,37+/m1/s1
Standard InChI Key: VBGVAVOPKRZUPY-CFFNIIHUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 941.19 | Molecular Weight (Monoisotopic): 940.5858 | AlogP: -0.45 | #Rotatable Bonds: 27 |
Polar Surface Area: 337.36 | Molecular Species: ZWITTERION | HBA: 11 | HBD: 11 |
#RO5 Violations: 3 | HBA (Lipinski): 21 | HBD (Lipinski): 14 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.94 | CX Basic pKa: 11.63 | CX LogP: -2.44 | CX LogD: -5.40 |
Aromatic Rings: 1 | Heavy Atoms: 67 | QED Weighted: 0.03 | Np Likeness Score: 0.09 |
1. Gorman DM, Li XX, Lee JD, Fung JN, Cui CS, Lee HS, Rolfe BE, Woodruff TM, Clark RJ.. (2021) Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity., 64 (22.0): [PMID:34762432] [10.1021/acs.jmedchem.1c01174] |
Source(1):